Nome Químico: (3aR,4R,5aS,5bS,7S,11aS,11bR,12S,13aS)-7,11b-Difluoro-12-hydroxy-4,11a-dimethyl-3,9-dioxo-5,5a,5b,6,7,9,11a,11b,12,13-decahydro-1H,3H-naphtho[2',1':4,5]indeno[1,7a-c]thiophen-3a(4H)-yl propionate
Sorrisos: C[C@@]12[C@@]3(F)[C@@H](O)C[C@@]45[C@](C(SC5)=O)(OC(CC)=O)[C@H](C)C[C@@]4([H])[C@]3([H])C[C@H](F)C1=CC(C=C2)=O
Inchi: InChI=1S/C26H33F3O5S/c1-13(2)21(32)34-26(22(33)35-12-27)14(3)8-16-17-10-19(28)18-9-15(30)6-7-23(18,4)25(17,29)20(31)11-24(16,26)5/h6-7,9,13-14,16-17,19-20,31H,8,10-12H2,1-5H3/t14-,16+,17+,19+,20+,23+,24+,25+,26+/m1/s1
Characterisation of impurities in bulk drug batches of fluticasone propionate using directly coupled HPLC–NMR spectroscopy and HPLC–MS
Nisha Mistry a , Ismail M. Ismail b , Marco S. Smith c , Jeremy K. Nicholson d , John C. Lindon
Journal of Pharmaceutical and Biomedical Analysis 16 (1997) 697–705